144 related articles for article (PubMed ID: 6762217)
1. [Intravenous glucose tolerance test in the polycystic ovary syndrome].
Relli P; Cotrozzi G; Matteini M; Lazzari T; Bufalini GN
Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1451-4. PubMed ID: 6762217
[TBL] [Abstract][Full Text] [Related]
2. [Oral glucose tolerance test in polycystic ovary syndrome].
Cotrozzi G; Matteini M; Relli P; Lazzari T; Bufalini GN
Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1446-50. PubMed ID: 6762216
[TBL] [Abstract][Full Text] [Related]
3. [Hyperinsulinism and insulin resistance in the polycystic ovary syndrome as tested with tolbutamide].
Matteini M; Cotrozzi G; Bufalini GN; Relli P; Lazzari T
Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1455-60. PubMed ID: 6762218
[TBL] [Abstract][Full Text] [Related]
4. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
[TBL] [Abstract][Full Text] [Related]
5. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
7. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
Kurioka H; Takahashi K; Miyazaki K
Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
[TBL] [Abstract][Full Text] [Related]
8. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
Noyan V; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
10. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
12. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
[TBL] [Abstract][Full Text] [Related]
13. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinism and insulin resistance in polycystic ovarian syndrome: a verification using oral glucose, I.V. Glucose and tolbutamide.
Cotrozzi G; Matteini M; Relli P; Lazzari T
Acta Diabetol Lat; 1983; 20(2):135-42. PubMed ID: 6224386
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemia in polycystic ovary disease.
Arthur LS; Selvakumar R; Seshadri MS; Seshadri L
J Reprod Med; 1999 Sep; 44(9):783-7. PubMed ID: 10509302
[TBL] [Abstract][Full Text] [Related]
17. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
[TBL] [Abstract][Full Text] [Related]
19. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
Vagiri D; Barletta C; Cioli I; Scavo D
Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
[TBL] [Abstract][Full Text] [Related]
20. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Uncu G; Ozyurek SE; Uncu Y
Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
